DAG1 glycosylations
ENDO T. Mammalian O-mannosyl glycans: Biochemistry and glycopathology. Proceedings of the Japan Academy. Ser. B: Physical and Biological Sciences. 2019 Jan 11;95(1):39–51. doi: 10.2183/pjab.95.004.; Endo T. Glycobiology of -dystroglycan and muscular dystrophy. Journal of Biochemistry. 2014 Nov 07;157(1):1–12. doi: 10.1093/jb/mvu066.; Praissman JL, Wells L. Mammalian O-mannosylation pathway: glycan structures, enzymes, and protein substrates. Biochemistry. 2014 May 20;53(19):3066–78. PMID: 24786756; PMCID: PMC4033628.; Live D, Wells L, Boons GJ. Dissecting the molecular basis of the role of the O-mannosylation pathway in disease: a-dystroglycan and forms of muscular dystrophy. Chembiochem. 2013 Dec 16;14(18):2392–402. PMID: 24318691; PMCID: PMC3938021.; Wells L. The O-Mannosylation Pathway: Glycosyltransferases and Proteins Implicated in Congenital Muscular Dystrophy. Journal of Biological Chemistry. 2013 Mar;288(10):6930–5. doi: 10.1074/jbc.r112.438978.; Sparks SE. Congenital protein hypoglycosylation diseases. Appl Clin Genet. 2012;5():43–54. PMID: 23776380; PMCID: PMC3681192.; Tran DT, Lim JM, Liu M, Stalnaker SH, Wells L, Ten Hagen KG, Live D. Glycosylation of a-dystroglycan: O-mannosylation influences the subsequent addition of GalNAc by UDP-GalNAc polypeptide N-acetylgalactosaminyltransferases. J Biol Chem. 2012 Jun 15;287(25):20967–74. PMID: 22549772; PMCID: PMC3375520.